• HOME
  • CONTACT US
  • MEMBER RESOURCES
  • LOGIN
734.232.0043  |  MOQC@MOQC.ORG
Michigan Oncology Quality Consortium (MOQC)
  • About
    • ABOUT MOQC
      • Our Story
      • Our Team
      • FAQs
      • POQC: Patient and Caregiver Oncology Quality Council
      • Testimonials
      • Contact Us
    • MEMBERS
      • Participating Practices
      • Physician Champions
      • Join MOQC
    • COMMITTEES
      • Steering Committee
      • Measures Committee
  • Abstraction
    • ABSTRACTION RESOURCES
      • MOQC Abstraction
      • MOQCLink & Abstraction Resources
      • MOQC Measures
  • Patients/Caregivers
    • Patient and Caregiver Quality Council
      • About POQC
    • Centering Equity
      • BVOGUE – Black Voices on Gynecologic Cancer: Understanding Experiences
    • Patient and Caregiver Resources
      • Educational Events
      • Resources Search
      • Ovarian Cancer Resources
  • Initiatives
    • CLINICAL
      • CINV: Chemotherapy-Induced Nausea and Vomiting – Antiemetics
      • Hospice
      • Oral Oncolytics
      • Palliative Radiation Therapy Pathway
      • POEM: Pharmacists Optimizing Oncology Care Excellence in Michigan
      • PCOM: Primary Care Oncology Model
      • Tobacco Cessation Program
    • GRANT-FUNDED
      • MiGHT: Michigan Genetic Hereditary Testing Study
    • GYNECOLOGIC ONCOLOGY
      • Gyn Onc Educational Series
      • Ovarian Cancer Resources
      • Past Meeting Library
      • Standardized Op Note
      • VTE Khorana Calculator
      • VTE Prophylaxis Calculator
      • Opioid Calculator
  • News & Events
    • NEWS RESOURCES
      • Newsletters
      • Publications & Articles
    • EVENTS
      • Events
      • Past Meeting Library
  • Resources
    • CLINICAL RESOURCES
      • Biosimilars
      • CINV: Chemotherapy-Induced Nausea and Vomiting – Antiemetics
      • Fertility
      • Herbal Supplements
      • Hospice
      • Oral Oncolytics
      • Palliative Care
      • Tobacco Cessation
    • PRACTICE RESOURCES
      • Bill for What You Do Webinar
      • Outpatient Medical Benefit Revenue Cycle
    • CONTINUING EDUCATION
      • Claiming CE Credits
      • Continuing Education Opportunities
      • Maintenance of Certification
    • EQUITY OF CARE
      • Collecting REaL Data
      • Sexual and Gender Minorities
      • Telehealth
    • GYNECOLOGIC ONCOLOGY
      • Gyn Onc Educational Series
      • Ovarian Cancer Resources
      • Past Meeting Library
      • Standardized Op Note
      • VTE Khorana Calculator
      • VTE Prophylaxis Calculator
      • Opioid Calculator
    • MOQC
      • Becoming a MOQC Practice
      • MOQC Measures
      • VBR: Value-Based Reimbursement
      • Past Meeting Library
      • Printed Resources
  • Search
  • Menu Menu
Click here for the American Cancer Society’s 2023 Cancer Facts & Figures

Recent MOQC Publications

2022

  • Pituch KJ, Simon N, Weaver MS, Lindley LC. Preparing a Pediatric Palliative Care Program for Sustainable Support: A Practice Reflection. J Neurosci Nurs. 2022 Oct 1;54(5):199-200. doi: 10.1097/JNN.0000000000000659. Epub 2022 Jun 21. PMID: 36053088.
  • Mackler ER, Azar MK, Johengen E, Farris KB, Thompson AN. Feasibility of a comprehensive medication review to improve medication use for patients with cancer and comorbid conditions. Support Care Cancer. 2022 Oct 20. doi: 10.1007/s00520-022-07413-8. Epub ahead of print. PMID: 36264359.
  • Mackler E, Wietzke J, Schwartz A, Young K, Reyes-Gastelum D, Griggs JJ, Choe HM, Farris KB. Characterization of an embedded clinical oncology pharmacy model across the State of Michigan. Journal of Clinical Oncology 2022 40:28_suppl, 58-58
  • Resnicow K, Delacroix E, Chen G, Austin S, Stoffel E, Hanson EN, Gerido LH, Kaphingst KA, Yashar BM, Marvin M, Griggs JJ, Cragun D. Motivational interviewing for genetic counseling: A unified framework for persuasive and equipoise conversations. J Genet Couns. 2022 Oct;31(5):1020-1031. doi: 10.1002/jgc4.1609. Epub 2022 Jul 30. PMID: 35906848.
  • Wang CC, Rush SK, Uppal S, Rice LW, Spencer RJ. Trends in public- and industry-funded uterine cancer clinical trials and disability-adjusted life years from 2007 to 2019. Am J Obstet Gynecol. 2022 Oct;227(4):666-668. doi: 10.1016/j.ajog.2022.06.016. Epub 2022 Jun 17. PMID: 35724760.
  • Coffman LG, Orellana TJ, Liu T, Frisbie LG, Normolle D, Griffith K, Uppal S, McLean K, Berger J, Boisen M, Courtney-Brooks M, Edwards RP, Lesnock J, Mahdi H, Olawaiye A, Sukumvanich P, Taylor SE, Buckanovich R. Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer. JCI Insight. 2022 Sep 22;7(18):e160573. doi: 10.1172/jci.insight.160573. PMID: 35972817 Free article. Clinical Trial.
  • Gainsburg I, Derricks V, Shields C, Fiscella K, Epstein R, Yu V, Griggs J. Patient activation reduces effects of implicit bias on doctor-patient interactions. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203915119. doi: 10.1073/pnas.2203915119. Epub 2022 Aug 1. PMID: 35914161; PMCID: PMC9371681.
  • Ferragamo T, Pituch KJ, Sorkin T, Simon N, Lindley LC, Weaver MS. A Narrative Review of Pediatric Respite Care Initiatives in the United States. J Hosp Palliat Nurs. 2022 Aug 1;24(4):E172-E182. doi: 10.1097/NJH.0000000000000867. Epub 2022 Apr 25. PMID: 35470307.
  • Russo RM, Carver A, Clifford C, Rolston A, Uppal S, Napolitano LM. A team approach to peripartum hemorrhage control incorporating resuscitative endovascular balloon occlusion of the aorta. J Trauma Acute Care Surg. 2022 Aug 1;93(2):e89-e94. doi: 10.1097/TA.0000000000003612. Epub 2022 Mar 22. PMID: 35319543.
  • Rocque GB, Wheeler SB, Griggs J. Growing the Next Generation of Oncology Researchers and Oncologists. JCO Oncol Pract. 2022 Aug;18(8):559-561. doi: 10.1200/OP.21.00873. Epub 2022 Feb 14. PMID: 35157513; PMCID: PMC9377688.
  • Mojdehbakhsh RP, Mora Hurtado AC, Uppal S, Milakovich H, Spencer RJ. The long game: Telemedicine patient satisfaction metrics and methods of recurrence detection for gynecologic cancer patients throughout the initial year of the COVID-19 pandemic. Gynecol Oncol Rep. 2022 Jul 8;42:101037. doi: 10.1016/j.gore.2022.101037. PMID: 35855966; PMCID: PMC9287468.
  • Janke MJ, Santiago S, Straubhar AM, Uppal S. The utility of physical examination in ovarian cancer recurrence detection: a retrospective analysis informing virtual surveillance care. Int J Gynecol Cancer. 2022 Jul 4;32(7):913-917. doi: 10.1136/ijgc-2022-003506. PMID: 35675968.
  • Farris KB, Cadwallader T, Farley J, Gatwood K, Mackler E, Gatwood J. Implementation of a model integrating primary and oncology pharmacists’ care for patients taking oral anticancer agents (OAA). Explor Res Clin Soc Pharm. 2022 Jul 29;7:100163. doi: 10.1016/j.rcsop.2022.100163. PMID: 35957656; PMCID: PMC9358049.
  • Hertz DL, Chen L, Henry NL, Griggs JJ, Hayes DF, Derstine BA, Su GL, Wang SC, Pai MP. Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing. Br J Clin Pharmacol. 2022 Jul;88(7):3222-3229. doi: 10.1111/bcp.15244. Epub 2022 Feb 14. PMID: 35083783; PMCID: PMC9197985.
  • Davidson A, Mackler E. What Centering the Patient Means: A Pharmacy Student Perspective. HOPA News. 2022 Volume 19, Issue 2.
  • Belcher SM, Mackler E, Muluneh B, Ginex PK, Anderson MK, Bettencourt E, DasGupta RK, Elliott J, Hall E, Karlin M, Kostoff D, Marshall VK, Millisor VE, Molnar M, Schneider SM, Tipton J, Yackzan S, LeFebvre KB, Sivakumaran K, Waseem H, Morgan RL. ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications. Oncol Nurs Forum. 2022 Jun 17;49(4):279-295. doi: 10.1188/22.ONF.279-295.PMID: 35788731
  • Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, Mackler E, Wallace L, Farris K, Rizvi-Toner A, Farley J. Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma. JCO Oncol Pract. 2022 Sep;18(9):e1475-e1483. doi: 10.1200/OP.22.00008. Epub 2022 Jun 14. PMID: 35700416.
  • Alpert AB, Mehringer JE, Orta SJ, Redwood E, Hernandez T, Rivers L, Manzano C, Ruddick R, Adams S, Cerulli C, Operario D, Griggs JJ. Experiences of Transgender People Reviewing Their Electronic Health Records, a Qualitative Study. J Gen Intern Med. 2022 May 31. doi: 10.1007/s11606-022-07671-6. Epub ahead of print. PMID: 35641720.
  • Edupuganti S, Li M, Wu Z, Basu T, Barnes GD, Carrier M, Sood SL, Griggs JJ, Schaefer JK. Factors Associated With Inferior Vena Cava Filter Placement and Retrieval for Patients With Cancer-Associated Thrombosis. Am J Med. 2022 Apr;135(4):478-487.e5. doi: 10.1016/j.amjmed.2021.11.006. Epub 2021 Nov 30. PMID: 34861200.

2021

  • McDaniel SH, Morse DS, Edwardsen EA, Taupin A, Gurnsey MG, Griggs JJ, Shields CG, Reis S. Empathy and boundary turbulence in cancer communication. Patient Educ Couns. 2021 Dec;104(12):2944-2951. doi: 10.1016/j.pec.2021.04.002. Epub 2021 Apr 15. PMID: 33947581; PMCID: PMC8517043.
  • Pleasant VA, Griggs JJ. Contemporary Residential Segregation and Cancer Disparities. J Clin Oncol. 2021 Sep 1;39(25):2739-2741. doi: 10.1200/JCO.21.01328. Epub 2021 Jun 28. PMID: 34181464.
  • Lafferty M, Manojlovich M, Griggs JJ, Wright N, Harrod M, Friese CR. Clinicians Report Barriers and Facilitators to High-Quality Ambulatory Oncology Care. Cancer Nurs. 2021 Sep-Oct 01;44(5):E303-E310. doi: 10.1097/NCC.0000000000000832. PMID: 32482956; PMCID: PMC7704529.
  • Mendes de Leon CF, Griggs JJ. Medical Debt as a Social Determinant of Health. JAMA. 2021 Jul 20;326(3):228-229. doi: 10.1001/jama.2021.9011. PMID: 34283197.
  • Chen CS, Kim J, Garg N, Guntupalli H, Jagsi R, Griggs JJ, Sabel M, Dorsch MP, Callaghan BC, Hertz DL. Chemotherapy-Induced Peripheral Neuropathy Detection via a Smartphone App: Cross-sectional Pilot Study. JMIR Mhealth Uhealth. 2021 Jul 5;9(7):e27502. doi: 10.2196/27502. PMCID: PMC8406129.
  • Wallner LP, Abrahamse P, Gargaro JG, Radhakrishnan A, Mullins MA, An LC, Griggs JJ, Schott AF, Ayanian JZ, Sales AE, Katz S, Hawley ST.  Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trial. Breast Cancer Res Treat. 2021 Jul 7. doi: 10.1007/s10549-021-06257-w. Online ahead of print. PMID: 34235608
  • Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz CD, Shayne M, Sparreboom A, Turner S, Zarwan C, Lyman GH.  Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2021 May 3:JCO2100471. doi: 10.1200/JCO.21.00471. Online ahead of print.  PMID: 33939491
  • Patel MR, Jagsi R, Resnicow K, Smith SN, Hamel LM, Su C, Griggs JJ, Buchanan D, Isaacson N, Torby M. A Scoping Review of Behavioral Interventions Addressing Medical Financial Hardship. Popul Health Manag. 2021 May 14. doi: 10.1089/pop.2021.0043. Online ahead of print. PMID: 33989065
  • Friese CR, Mendelsohn-Victor K, Medvec BR, Ghosh B, Bedard L, Griggs JJ, Manojlovich M. Factors Associated With Job Satisfaction in Medical Oncology Practices: Results From a Multisite Survey. J Nurs Adm. 2021 Apr 1;51(4):200-205. doi: 10.1097/NNA.0000000000000998. PMID: 33734179; PMCID: PMC7988747.
  • Schaefer JK, Li M, Wu Z, Basu T, Barnes GD, Carrier M, Griggs JJ, Sood SL.  Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolism.  J Thromb Thrombolysis. 2021 Feb 5. doi: 10.1007/s11239-021-02392-9. Online ahead of print.  PMID: 33544284
  • Schaefer JK, Li M, Wu Z, Basu T, Dorsch MP, Barnes GD, Carrier M, Griggs JJ, Sood SL. Anticoagulant medication adherence for cancer-associated thrombosis: A comparison of LMWH to DOACs. J Thromb Haemost. 2021 Jan;19(1):212-220. doi: 10.1111/jth.15153. Epub 2020 Nov 21. PMID: 33104289.

2020

  • Friese CR, Fauer AJ, Kuisell C, Mendelsohn-Victor K, Wright NC, Griggs JJ, Manojlovich M. Patient-reported outcomes collected in ambulatory oncology practices: Feasibility, patterns, and correlates. Health Serv Res. 2020 Dec;55(6):966-972. doi: 10.1111/1475-6773.13574. Epub 2020 Oct 30. PMID: 33125170; PMCID: PMC7704472.
  • Dinan MA, Wilson LE, Reed SD, Griggs JJ, Norton EC. Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption. Clin Breast Cancer. 2020 Dec;20(6):487-494.e1. doi: 10.1016/j.clbc.2020.05.010. Epub 2020 May 26. PMID: 32653473.
  • Herrel LA, Zhu Z, Griggs JJ, Kaye DR, Dupree JM, Ellimoottil CS, Miller DC. Association Between Delivery System Structure and Intensity of End-of-Life Cancer Care. JCO Oncol Pract. 2020 Jul;16(7):e590-e600. doi: 10.1200/JOP.19.00667. Epub 2020 Feb 18. PMID: 32069191; PMCID: PMC7359774.
  • Griggs JJ. Improving the care of lesbian, gay, bisexual, transgender, and queer people with cancer through transformational approaches. JCO Oncol Pract. 2020 Jun;16(6):317-318. doi: 10.1200/OP.20.00373.  PMID: 32521219.
  • Emily R. Mackler, Kelly Marie Procailo, Louise Bedard, and Jennifer J. Griggs. State-wide quality improvement addressing overutilization of neurokinin-1 receptor antagonists. Journal of Clinical Oncology 2020 38:29_suppl, 8-8
  • Manojlovich M, Bedard L, Griggs JJ, McBratnie M, Mendelsohn-Victor K, Friese CR. Facilitators and Barriers to Recruiting Ambulatory Oncology Practices Into a Large Multisite Study: Mixed Methods Study. JMIR Cancer. 2020 Apr 20;6(1):e14476. doi: 10.2196/14476. PMID: 32310140; PMCID: PMC7199136.
  • Griggs JJ. Disparities in palliative care in patients with cancer. J Clin Oncol. 2020 Mar 20;38(9):974-979 DOI: 1200/JCO.19.02108 Epub Feb 5. PMID: 32023155
  • Jennaro TS, Lavole Smith EM, Vangipuram K, Kidwell KM, Burness ML, Griggs JJ, Van Posznak CH, Hayes DF, Henry NL, Hertz DL. Vitamin D insufficiency and risk of paclitaxel-induced peripheral neuropathy.  Breast Cancer Res Treat. 2020 Mar 12. doi: 10.1007/s10549-020-05584-8. [Epub ahead of print] PMID: 32166478
  • Emily R. Mackler, Amy Thompson. Pharmacists Bridging the Gap Between Oncology and Primary Care. Hope News 2020. Volume 17, Issue 3, Pg. 6.

2019

  • Nachar VR, Farris K, Beekman K, Griggs J, Hough S, Mackler E. Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM). JCO Clin Cancer Inform. 2019 May;3:1-6. doi: 10.1200/CCI.18.00128. PMID: 31100014.
  • Patel MR, Friese CR, Mendelsohn-Victor K, Fauer AJ, Ghosh B, Bedard L, Griggs JJ, Manojlovich M. Clinician Perspectives on Electronic Health Records, Communication, and Patient Safety Across Diverse Medical Oncology Practices. J Oncol Pract. 2019 Jun;15(6):e529-e536. doi: 10.1200/JOP.18.00507. Epub 2019 Apr 22. PMID: 31009284; PMCID: PMC6804874.
  • Mackler E, Segal EM, Muluneh B, Jeffers K, Carmichael J. 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard. J Oncol Pract. 2019 Apr;15(4):e346-e355. doi: 10.1200/JOP.18.00581. Epub 2019 Mar 12. PMID: 30860937; PMCID: PMC6494244.
  • Stevenson JG, LaPointe S, Sabourin A, Reyes RJ, Phalen MJ, Mackler ER. Implementing a specialty pharmacy course within a professional pharmacy curriculum. Curr Pharm Teach Learn. 2019 Jan;11(1):106-113. doi: 10.1016/j.cptl.2018.09.013. Epub 2018 Oct 6. PMID: 30527871.

2018

  • Samkeliso Beusterien, Louise Bedard, and Jennifer J. Griggs. Implementation of a regional structure across an oncology collaborative quality initiative and the impact on physician engagement. Journal of Clinical Oncology 2018 36:30_suppl, 149-149
  • Mackler E, Scappaticci GB, Salgado TM, Petersen L, Davis EJ, Peltier E, Griggs JJ, Sabo RT, Farris KB. Impact of a Statewide Oral Oncolytic Initiative on Five Participating Practices. J Oncol Pract. 2018 May;14(5):e304-e309. doi: 10.1200/JOP.18.00058. Epub 2018 Apr 11. PMID: 29641272.
  • Vulaj V, Hough S, Bedard L, Farris K, Mackler E. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care. J Oncol Pract. 2018 Jun;14(6):e403-e411. doi: 10.1200/JOP.2017.026666. Epub 2018 Jan 3. PMID: 29298114.

Selected Quality Initiative Publications

End of Life

  • Ananth P, Mun S, Reffat N, Kang SJ, Pitafi S, Ma X, Gross CP, Wolfe J. Refining Patient-Centered Measures of End-of-Life Care Quality for Children With Cancer. JCO Oncol Pract. 2021 Oct 6:OP2100447. doi: 10.1200/OP.21.00447. Epub ahead of print. PMID: 34613797.
  • Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M, Lakin J, Desai M, Lamas D, Sanders JJ, Gass J, Henrich N, Lipsitz S, Fromme E, Gawande AA, Block SD. Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program. JAMA Oncol. 2019 Jun 1;5(6):801-809. doi: 10.1001/jamaoncol.2019.0292. PMID: 30870556.

Tobacco Cessation

  • Gennette RL. Improving smoking cessation education and documentation. J Am Assoc Nurse Pract. 2021 Aug 19. doi: 10.1097/JXX.0000000000000630. Epub ahead of print. PMID: 34469361.

Fertility

  • Sena LA, Sedhom R, Scott S, Kagan A, Marple AH, Canzoniero JV, Hsu M, Qasim Hussaini SM, Herati AS, Reschke L, Antero MF, Christianson MS, Binder AF, Chen AR, Donehower RC, Marrone KA, Gupta A. Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer. JCO Oncol Pract. 2021 Sep 25:OP2100479. doi: 10.1200/OP.21.00479. Epub ahead of print. PMID: 34565170.

Gynecologic Oncology

  • Andreassen T, Weiderpass E, Nicula F, Suteu O, Itu A, Bumbu M, Tincu A, Ursin G, Moen K. Controversies about cervical cancer screening: A qualitative study of Roma women’s (non)participation in cervical cancer screening in Romania. Soc Sci Med. 2017 Jun;183:48-55. doi: 10.1016/j.socscimed.2017.04.040. Epub 2017 Apr 26. PMID: 28460211.
  • Seagle BL, Butler SK, Strohl AE, Nieves-Neira W, Shahabi S. Chemotherapy delay after primary debulking surgery for ovarian cancer. Gynecol Oncol. 2017 Feb;144(2):260-265. doi: 10.1016/j.ygyno.2016.11.022. Epub 2016 Nov 29. PMID: 27908531.
  • Rocher G, Gaillard T, Uzan C, Collinet P, Bolze PA, Ballester M, Bendifallah S, Ouldamer L, Touboul C, Huchon C, Lavoue V, Dabi Y, Akladios C, Coutant C, Raimond E, Bricou A, Canlorbe G, Azaïs H. Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. J Clin Med. 2021 Mar 4;10(5):1058. doi: 10.3390/jcm10051058. PMID: 33806443; PMCID: PMC7961531
  • Wu MF, Liang JX, Li H, Ye YF, Liang WF, Wang LJ, Zhang BZ, Chen Q, Lin ZQ, Li J. Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high-grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study. BJOG. 2022 Nov;129 Suppl 2:5-13. doi: 10.1111/1471-0528.17323. PMID: 36485072.

Financial Navigation/Toxicity

  • Marion S, Aviki E, Chino F. Financial toxicity of surgical treatment for gynecological cancer: A growing malignancy. Gynecol Oncol. 2022 Aug;166(2):197-199. doi: 10.1016/j.ygyno.2022.07.007. PMID: 35882468.

Quality Improvement

  • Keating NL, Jhatakia S, Brooks GA, et al. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes. JAMA. 2021;326(18):1829–1839. doi:10.1001/jama.2021.17642
  • Standiford T, Conte ML, Billi JE, Sales A, Barnes GD. Integrating Lean Thinking and Implementation Science Determinants Checklists for Quality Improvement: A Scoping Review. Am J Med Qual. 2020 Jul/Aug;35(4):330-340. doi: 10.1177/1062860619879746. Epub 2019 Oct 4. PMID: 31581794; PMCID: PMC7327705.
  • Bernacki R, Paladino J, Neville BA, Hutchings M, Kavanagh J, Geerse OP, Lakin J, Sanders JJ, Miller K, Lipsitz S, Gawande AA, Block SD. Effect of the Serious Illness Care Program in Outpatient Oncology: A Cluster Randomized Clinical Trial. JAMA Intern Med. 2019 Jun 1;179(6):751-759. doi: 10.1001/jamainternmed.2019.0077. PMID: 30870563; PMCID: PMC6547155.

MOQC Mentions

  • Treatment Pathway: Palliative Radiation for Oncology Patients on Hospice, Value Partnership Update, October 2022; https://www.bcbsm.com/content/dam/microsites/corpcomm/provider/VPU/2022/oct/1022d.html
  • ‘I Feel So Lucky:’ Rochester Hills Woman With Terminal Ovarian Cancer Dedicates Life to Advocacy, Jake Newb, 09.27.2022; https://www.mibluesperspectives.com/stories/trend/i-feel-so-lucky-rochester-hills-terminal-ovarian-cancer-patient-dedicates-life-to-advocacy
Blue Cross Blue Shield of Michigan logo

Support for the Michigan Oncology Quality Consortium is provided by Blue Cross and Blue Shield of Michigan (BCBSM) as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. Although Blue Cross Blue Shield of Michigan and MOQC work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.

mission
© Copyright - Michigan Oncology Quality Consortium (MOQC) • Arbor Lakes • 4251 Plymouth Road • Ann Arbor, MI 48105
  • Twitter
  • LinkedIn
Scroll to top
TRANSLATE »